These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 27680891)

  • 21. Homozygous familial hypercholesterolaemia: update on management.
    France M
    Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of genetic defects on coronary atherosclerosis in patients suspected of having familial hypercholesterolaemia.
    Descamps OS; Gilbeau JP; Luwaert R; Heller FR
    Eur J Clin Invest; 2003 Jan; 33(1):1-9. PubMed ID: 12492446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New promoter mutations in the low-density lipoprotein receptor gene which induce familial hypercholesterolaemia phenotype: molecular and functional analysis.
    Francová H; Trbusek M; Zapletalová P; Kuhrová V
    J Inherit Metab Dis; 2004; 27(4):523-8. PubMed ID: 15303010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia.
    Pisciotta L; Sallo R; Rabacchi C; Wunsch A; Calandra S; Bertolini S
    Nutr Metab Cardiovasc Dis; 2012 Oct; 22(10):831-5. PubMed ID: 21920719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia.
    Streicher J; Valent P; Schmidt H; Sengölge G; Wagner O; Strobl W; Hörl WH; Derfler K
    J Investig Med; 1999 Sep; 47(8):378-87. PubMed ID: 10510590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LRP5 deficiency down-regulates Wnt signalling and promotes aortic lipid infiltration in hypercholesterolaemic mice.
    Borrell-Pagès M; Romero JC; Badimon L
    J Cell Mol Med; 2015 Apr; 19(4):770-7. PubMed ID: 25656427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic basis of familial hypercholesterolemia.
    Myant NB
    Klin Wochenschr; 1983 Apr; 61(8):383-401. PubMed ID: 6306334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of Human Liver Chimeric Mice with Hepatocytes from Familial Hypercholesterolemia Induced Pluripotent Stem Cells.
    Yang J; Wang Y; Zhou T; Wong LY; Tian XY; Hong X; Lai WH; Au KW; Wei R; Liu Y; Cheng LH; Liang G; Huang Z; Fan W; Zhao P; Wang X; Ibañez DP; Luo Z; Li Y; Zhong X; Chen S; Wang D; Li L; Lai L; Qin B; Bao X; Hutchins AP; Siu CW; Huang Y; Esteban MA; Tse HF
    Stem Cell Reports; 2017 Mar; 8(3):605-618. PubMed ID: 28262545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
    Wang J; Huff E; Janecka L; Hegele RA
    Hum Mutat; 2001 Oct; 18(4):359. PubMed ID: 11668627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating CD45+/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients.
    Suades R; Padró T; Alonso R; López-Miranda J; Mata P; Badimon L
    Thromb Haemost; 2014 Jan; 111(1):111-21. PubMed ID: 24085382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemia.
    Souverein OW; Defesche JC; Zwinderman AH; Kastelein JJ; Tanck MW
    Eur Heart J; 2007 Feb; 28(3):299-304. PubMed ID: 17090611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.
    Vongpromek R; Bujo H; Hoekstra M; Schneider WJ; van der Zee L; Schinkel AF; Korporaal SJ; Dik WA; Ebinuma H; Jiang M; Verhoeven AJ; Sijbrands EJ; Mulder MT
    Atherosclerosis; 2015 Dec; 243(2):429-37. PubMed ID: 26520897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentrations of the atherogenic Lp(a) are elevated in FH.
    Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G
    Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosome-based
    Li Z; Zhao P; Zhang Y; Wang J; Wang C; Liu Y; Yang G; Yuan L
    Theranostics; 2021; 11(6):2953-2965. PubMed ID: 33456582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defects.
    Lambert G; Petrides F; Chatelais M; Blom DJ; Choque B; Tabet F; Wong G; Rye KA; Hooper AJ; Burnett JR; Barter PJ; Marais AD
    J Am Coll Cardiol; 2014 Jun; 63(22):2365-73. PubMed ID: 24632287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of familial hypercholesterolaemia.
    Hovingh GK; Davidson MH; Kastelein JJ; O'Connor AM
    Eur Heart J; 2013 Apr; 34(13):962-71. PubMed ID: 23416791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and gender.
    Holven KB; Myhre AM; Aukrust P; Hagve TA; Ose L; Nenseter MS
    Eur Heart J; 2003 Oct; 24(19):1756-62. PubMed ID: 14522571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664----leu mutation in the LDL receptor gene.
    Soutar AK; McCarthy SN; Seed M; Knight BL
    J Clin Invest; 1991 Aug; 88(2):483-92. PubMed ID: 1830890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of low density lipoprotein receptor activity of lymphocytes to determine the prevalence of familial hypercholesterolaemia in a rural South African community.
    Steyn K; Weight MJ; Dando BR; Christopher KJ; Rossouw JE
    J Med Genet; 1989 Jan; 26(1):32-6. PubMed ID: 2918524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.